Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

Practice-changing data for J&J's Zytiga in prostate cancer

Practice-changing data for J&J's Zytiga in prostate cancer Johnson &Johnson is celebrating much-anticipated data for its prostate cancer therapy Zytiga that could see the drug being used first-line alongside conventional anti-androgen drugs. ... Sales of Zytiga were $523m in the first quarter of this year, down

Deal Watch May 2016

Deal Watch May 2016 outperforming J&J's Zytiga [abiraterone].

NICE changes tack on Sanofi's prostate cancer drug Jevtana

NICE changes tack on Sanofi's prostate cancer drug Jevtana Previously, NICE said that Sanofi had been unable to demonstrate that Jevtana was cost-effective compared to standard treatments such as Johnson &Johnson's Zytiga (abiraterone), Astellas/Medivation's Xtandi (enzalutamide) ... Blake pointed out that NICE

Sanofi takeover bid rebuffed by Medivation

Sanofi takeover bid rebuffed by Medivation Towards the end of last year the drug overtook rival therapy Johnson &Jonson's Zytiga (abiraterone) in the US in terms of new prescriptions, according to Medivation.

NICE backs Xtandi but turns down Zytiga

NICE backs Xtandi but turns down Zytiga The agency was less impressed with Johnson &Johnson's Zytiga (abiraterone acetate) however, turning it down as an option for pre-chemo use by the NHS in England and Wales and ... While also acknowledging that Zytiga is well-tolerated and delays the need

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...